Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab in erosive osteoarthritis of finger joints
NCT00296894Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- May 2006
- Primary completion
- Jan 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of adalimumab in erosive osteoarthritis (EOA), sponsored by Ghent University Hospital. Primary endpoints: Evaluation of x-rays at 1 year, Pain at 1 year and 1 more. Started May 2006; status: completed.
02
Drugs
03
Conditions
erosive osteoarthritis (EOA)
Beyond the preview
Go deeper on NCT00296894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296894.